Assets of eFFECTOR Therapeutics, Inc. from 31 Dec 2020 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: eFFECTOR Therapeutics, Inc. quarterly Assets in USD history and change rate from 31 Dec 2020 to 31 Mar 2024.
eFFECTOR Therapeutics, Inc. Assets for the quarter ending 31 Mar 2024 was $27,131,000, a 24% increase year-over-year.
Source SEC data: View on sec.gov

Assets, Quarterly (USD)

Assets, YoY Quarterly Change (%)

eFFECTOR Therapeutics, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$27,131,000	+$5,203,000	+24%	31 Mar 2024	10-Q	09 May 2024	2024	Q1
Q4 2023	$20,544,000	-$8,533,000	-29%	31 Dec 2023	10-Q	09 May 2024	2024	Q1
Q3 2023	$20,161,000	-$16,490,000	-45%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$26,889,000	-$16,582,000	-38%	30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q1 2023	$21,928,000	-$27,567,000	-56%	31 Mar 2023	10-Q	09 May 2023	2023	Q1
Q4 2022	$29,077,000	-$24,979,000	-46%	31 Dec 2022	10-K	26 Mar 2024	2023	FY
Q3 2022	$36,651,000	-$23,285,000	-39%	30 Sep 2022	10-Q	07 Nov 2022	2022	Q3
Q2 2022	$43,471,000	+$29,190,000	+204%	30 Jun 2022	10-Q	09 Aug 2022	2022	Q2
Q1 2022	$49,495,000	-$127,321,736	-72%	31 Mar 2022	10-Q	10 May 2022	2022	Q1
Q4 2021	$54,056,000	+$37,352,000	+224%	31 Dec 2021	10-K	08 Mar 2023	2022	FY
Q3 2021	$59,936,000			30 Sep 2021	10-Q	08 Nov 2021	2021	Q3
Q2 2021	$14,281,000			30 Jun 2021	8-K	31 Aug 2021
Q1 2021	$176,816,736			31 Mar 2021	10-Q	03 Jun 2021	2021	Q1
Q4 2020	$16,704,000			31 Dec 2020	10-K	16 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.